The Department of Veterans Affairs (VA) will no longer offer gender-affirming medical treatment to transgender former service ...

The department announced that patients currently being treated and those discharged from the Defense Department who receive ...

A new study shows the positive impact gender-affirming hormone therapy, or GAHT, can have on the depression rates for transgender adults.

The VA announced today that it will phase out medical treatments for gender dysphoria and no longer provide funding.

In this longitudinal observational cohort study, gender-affirming hormone therapy was associated with lower rates of ...

HealthDay News — For older women, menopausal hormone therapy (HT) use is associated with faster regional tau accumulation, according to a study published in the March 5 issue of Science Advances.

The Department of Veterans Affairs, which has a huge presence in the CSRA, announced Monday it will phase out medical treatments for gender dysphoria.

A new study by Mass General Brigham researchers has found faster accumulation of tau—a key indicator of Alzheimer's ...

The study’s researchers scanned the brains of older women who have used HT, observing tau accumulation, a hallmark of Alzheimer disease.

Alzheimer’s disease is more common in women, and hormones like estrogen are believed to play a role in brain aging. Around ...

Dr. Sara M. Tolaney discusses breast practices associated with CDK4/6 inhibitors for the treatment of breast cancer.